Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) EV/FCF
As of 5 November 2026, Privia Health Group, Inc. (PRVA) trades at a EV/FCF of 24.3×. Over the past ten years it has ranged from 12.2× (March 2026) to 679× (October 2022); the current reading is higher than 40% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 15.0× | (12.72%) |
| FY2024 | 17.2× | (42.54%) |
| FY2023 | 29.9× | (34.46%) |
| FY2022 | 45.7× | 4.86% |
| FY2021 | 43.6× | (12.97%) |
| FY2020 | 50.1× | 0.00% |
| FY2019 | 50.1× | 0.00% |
| FY2018 | 50.1× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 19.5× | (11.16%) |
| Jun 2026 | 21.9× | 39.20% |
| Mar 2026 | 15.7× | 4.77% |
| Dec 2025 | 15.0× | (37.39%) |
| 23 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| HTFL Heartflow, Inc. compare | −76.6× |
| SDGR Schrodinger, Inc. compare | −15.4× |
| GDRX GoodRx Holdings, Inc. compare | 10.5× |
| OMCL Omnicell, Inc. compare | 13.3× |
| DOCS Doximity, Inc. compare | 17.7× |
| TDOC Teladoc Health, Inc. compare | 22.7× |
| PRVA Privia Health Group, Inc. | 24.3× |
| WAY Waystar Holding Corp. compare | 25.3× |
| CERT Certara, Inc. compare | 37.6× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement